AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6%
Fri, 15 Nov

AUROBINDO PHARMA has announced its results for the quarter ended September 2019. Here is a detailed performance review of the same:

AUROBINDO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-18*
3
Jun-19*
3
Sep-19*
QoQ ChangeYoY Change
Net SalesRs m47,51454,44656,0052.9%17.9%
Other incomeRs m26315820630.7%-21.5%
TurnoverRs m47,77754,60456,2112.9%17.7%
ExpensesRs m37,65142,98244,6033.8%18.5%
Gross profitRs m9,59411,33711,275-0.6%17.5%
DepreciationRs m1,6372,4092,4331.0%48.6%
InterestRs m354499409-17.9%15.7%
Profit before taxRs m7,8668,5878,6380.6%9.8%
TaxRs m1,7542,2782,244-1.5%27.9%
Profit after taxRs m6,1126,3106,3951.3%4.6%
Gross profit margin%20.220.820.1
Effective tax rate%22.326.526.0
Net profit margin%12.811.611.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 17.9% on a year-on-year (YoY) basis. The expenses were up by 18.5% YoY during the same period.
  • The company's operating profit increased by 17.5% YoY during the quarter. Consequently, operating profit margins remained same and stood at 20.1% in 2QFY20.
  • Depreciation charges increased by 48.6% and finance costs increased by 15.7% YoY, respectively.
  • Other income declined by 21.5% YoY during the quarter.
  • Net profit for the quarter increased by 4.6% YoY. Net profit margins during the quarter declined from 12.8% in 2QFY19 to 11.4% in 2QFY20.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 2.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.8% QoQ during the same period.
  • The company's operating profit declined by 0.6% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 20.1% in 2QFY20 as against 20.8% in 1QFY19.
  • Net profit for the quarter increased by 1.3% QoQ, while net profit margins declined from 11.6% in 1QFY19 to 11.4% in 2QFY20.

To see how AUROBINDO PHARMA has performed over the last eight quarters,please visit here.

Listen In: Our Investor Hour Podcast Connects You with the World's Most Successful Investors

AUROBINDO PHARMA Share Price Performance

Over the last one year,AUROBINDO PHARMA share price has moved down from Rs 780.2 to Rs 401.7, registering a Loss of Rs 378.5 or around 48.5%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,958.4 (up 0.3%). Over the last one year it has moved down from 14,276.6 to 12,958.4, a gain of 1,318 points (down 9.2%).

Overall, the S&P BSE SENSEX is up 15.2% over the year.

Current Valuations

At the current price of Rs 401.7, the price to earnings (P/E) ratio of AUROBINDO PHARMA stands at 9.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 1.7 times.

Equitymaster requests your view! Post a comment on "AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6%". Click here!

  

Related Views on News

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 38.6% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 38.6% YoY). Sales on the other hand came in at Rs 54 bn (up 28.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Dec 11, 2019 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - SANOFI INDIA COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS